Staphylococcus aureus strains associated with toxic shock syndrome produce toxic shock syndrome toxin 1 (TSST1). This toxin has a variety of biological effects, including enhanced lethality in rabbits in the presence of sublethal amounts of lipopolysaccharide (LPS). Because chicken embryos are highly susceptible to LPS, the synergistic effect of TSST1 and LPS was examined in this system. Although TSST1 per se had no effect on chicken embryos, it potentiated the lethal effect of LPS. The 50% lethal dose of LPS was greatly reduced in the presence of up to 10 ,ug of TSST1 per ml. However, at high doses of TSST1 (>100 ,ug/ml), no enhanced lethality was observed. The lowest dose of TSST1 tested which potentiated lethality was 10 ng/ml.
Staphylococcal toxic shock syndrome (TSS) is an acute multisystem disease characterized by fever, rash, vomiting, diarrhea, and clinical shock. Most Staphylococcus aureus strains associated with TSS produce a 23,000-dalton exoprotein with a pl of 7.3. Although this protein has been referred to as PEC (18) , SEF (2), TSF (5), TSSE (11) , TSA (15) , or TST (13) , it was recently decided to call it TSS toxin 1 (TSST1) (la) .
TSST1 is mitogenic for human lymphocytes (18) and stimulates the release of interleukin 1 from human monocytes (10) . It enhances capillary permeability and elicits a pyrogenic response in rabbits (5, 18) . It is also lethal in rabbits, and the effect is potentiated by gram-negative lipopolysaccharide (LPS) (5, 16, 18) . It has no effect on other laboratory animals or on tissue culture cells (5) .
The effect on rabbits is unpredictable for a variety of reasons. There is an age difference (5) and a strain difference (6; R. Stone, G. Johnson, and H. Pickrum, Abstr. Annu. Meet. Am. Soc. Microbiol. 1984, B53, p. 26) in susceptibility to TSST1. Because of this we felt that rabbits were not a good model for routine biological assays. We therefore sought other systems in which TSST1 may have an effect. In view of the synergism between TSST1 and LPS, we chose chicken embryos because they are highly susceptible to LPS (19) . In this paper, we show that although TSST1 per se has no effect on chicken embryos, it is lethal in the presence of sublethal amounts of LPS. The chicken embryo assay could, therefore, be used as a quick and reproducible bioassay for TSST1. MATERIALS with a dye concentrate (Bio-Rad Laboratories, Richmond, Calif.) and with bovine gamma globulin as a standard; the optical density was read after 15 min at room temperature. Contamination of TSST1 with LPS was assessed by the Limulus amoebocyte lysate (E-toxate; Sigma Chemical Co., St. Louis, Mo.) gelation assay; purified TSST1 contained <0.5 ng of LPS per mg of TSST1.
Chicken embryo assays. Fertile hens eggs were set in a humidified, self-turning incubator maintained at 37°C. After 11 days of incubation, they were inoculated through a blood vessel, usually the chorioallantoic vein, by the method of Finkelstein (8) . Dilutions of TSST1 and LPS from Escherichia coli (E. coli 0111 LPS; Mallinckrodt, St. Louis, Mo.) were made in 0.85% (wt/vol) pyrogen-free saline (Wellcome Laboratories, Beckenham, Kent, United Kingdom); 100-,ul volumes of TSST1, LPS, or mixtures of TSST1 and LPS were injected into groups of 8 to 10 eggs per dose. Eggs were examined for death 24 h after the injection.
Antiserum to TSST1. New Zealand White rabbits (6 months old) were injected intradermally in multiple sites on their backs with 20 ,ug of TSST1 in Freund incomplete adjuvant. After 2 weeks, the dose was increased to 30 ,ug, followed by two subsequent doses of 60 pg each at 2-week intervals. Rabbits were bled after 7 weeks, and immunoglobulins were purified by ammonium sulfate precipitation (9) .
RESULTS
TSST1 per se at doses of up to 100 ,ug/ml had no apparent effect on chicken embryos. The mean 50% lethal dose (LD50) of LPS was 0.45 jig/ml (95% confidence limits, 0.29 to 0.61); doses of 0.1 j.ug/ml or less had no effect. However, when TSST1 and sublethal doses of LPS were injected together, there was a marked potentiation of lethality ( Table 1 ). The LD50 of LPS decreased to 0.05 ,ig/ml when a I-,ug/ml dose of TSST1 was also administered, and a similar enhancement was observed with 10 ,ug of TSST1 per ml.
Surprisingly, a 100-p.g/ml dose of TSST1 did not potentiate the lethal effect. This unexpected phenomenon occurred at all the sublethal LPS concentrations used (Table 1) and was confirmed with a wider range of TSST1 doses and a single dose of LPS (Table 2 ). Doses of TSST1 from 0.01 to 50 ,g/ml potentiated the lethal effect, but mortality decreased with higher doses, and a 250-,ug/ml dose was nontoxic.
The synergistic effect was neutralized when TSST1 was preincubated with anti-TSST1 serum for 30 min before being mixed with LPS (Table 3) . DISCUSSION Although TSST1 per se had no effect on chicken embryos, it is clear that it potentiates the lethality of LPS, because the LD50 of LPS was reduced ca. 10-fold by TSST1 concentrations of up to 50 ,ug/ml. The molecular basis of this synergism is unknown. LPS causes extensive perivascular hemorrhaging in chicken embryos (19) , and death is preceded by severe hypoglycemia (8) . Whether TSST1 and LPS in combination induce other lesions remains to be seen.
As has been suggested in the rabbit model (16, (5) . Although TSST1 per se is lethal in rabbits (5), it is likely that death occurs through a synergistic effect with endogenous circulating LPS, because rabbits pretreated with polymyxin B, which neutralizes the effect of LPS, were not susceptible to TSST1 (6) . It is possible that TSST1 may bind to LPS, thus enhancing the way in which the latter is "presented" to target cells; in the presence of excess TSST1, the binding sites of LPS for target cells may be masked.
In this study, the lowest dose of TSST1 (in combination with 0.1 ,ug of LPS per ml) which killed just under 50% of the embryos was 10 ng/ml. The chicken embryo assay therefore provides a reasonably sensitive bioassay for TSST1. Biological assays for TSST1 have been based on its pyrogenic or lethal effect on rabbits (5, 16, 18) , and it was recently suggested that a bioassay for TSST1 should be based on its ability to release interleukin 1 from monocytes (10) . Assays 
